Look For Institutional Buying In Phillips 66 (NYSE: PSX)

Barclays Bank Plc has recently announced that it has increased stake in Phillips 66 (NYSE:PSX) by 4.54%. After grabbing 6.25 million shares, the institutional investor is now in possession of 0.27 million shares of the Energy Company. The new investment brought the stake of investor firm to 1.40% having worth around $712.39 million. Moreover, Northern […]

Viking Therapeutics Inc (NASDAQ: VKTX) – Not A Clear Buying Opportunity?

Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $146.57 million. […]

There Is Clear Momentum For GE HealthCare Technologies Inc (NASDAQ: GEHC)

Capital Research & Management Co has recently announced that it has increased stake in GE HealthCare Technologies Inc (NASDAQ:GEHC) by 0.75%. After grabbing 49.94 million shares, the institutional investor is now in possession of 0.37 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 10.98% having worth around […]

Lattice Semiconductor Corp. (NASDAQ: LSCC) Not A Good Play Anymore?

Fidelity Management & Research Co has recently announced that it has increased stake in Lattice Semiconductor Corp. (NASDAQ:LSCC) by 5.94%. After grabbing 14.34 million shares, the institutional investor is now in possession of 0.8 million shares of the Technology Company. The new investment brought the stake of investor firm to 10.39% having worth around $797.32 […]

NeuroSense Therapeutics Ltd (NASDAQ: NRSN): To Buy Or Not To Buy, That Is The Question

After grabbing 11702.0 shares, the institutional investor is now in possession of 11702.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.09% having worth around $5395.0. Moreover, UBS Securities LLC increased its share by 9665.0 to have a control over 9665.0 shares. NeuroSense Therapeutics Ltd (NRSN) concluded trading […]

Some Investing Thoughts On Apollo Global Management Inc (NYSE: APO)

Apollo Global Management Inc (APO) concluded trading on 12/14/23 at a closing price of $93.13, with 4.3 million shares of worth about $400.2 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 20.34% during that period and on Thursday the price saw a gain […]

Cymabay Therapeutics Inc (NASDAQ: CBAY): Do Not Miss The Gain Train

BlackRock Fund Advisors has recently announced that it has increased stake in Cymabay Therapeutics Inc (NASDAQ:CBAY) by 5.53%. After grabbing 7.0 million shares, the institutional investor is now in possession of 0.37 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.21% having worth around $114.63 million. Moreover, […]

Set Your Sights On Invitation Homes Inc (NYSE: INVH)’S Upside Potential

Norges Bank Investment Management has recently announced that it has increased stake in Invitation Homes Inc (NYSE:INVH) by 3.44%. After grabbing 38.03 million shares, the institutional investor is now in possession of 1.27 million shares of the Real Estate Company. The new investment brought the stake of investor firm to 6.21% having worth around $1.13 […]

An Important Check-Up On Borr Drilling Ltd (NYSE: BORR)

Borr Drilling Ltd (BORR) concluded trading on 12/14/23 at a closing price of $7.02, with 4.45 million shares of worth about $31.27 million changed hands on the day. Thursday the price saw a gain of about 7.18%. Currently the company’s common shares owned by public are about 228.95M shares, out of which, 217.02M shares are […]